Stay Updated On Crucial Trends To Chalk Positive Growth Curve
Total Reports: 15
Rise in the number of patients suffering from non-Hodgkin’s lymphoma is the factor responsible for the growth of non-Hodgkin’s lymphoma therapeutics market.
Rep Id : TMRGL2668 | Published | Pharmaceutical | July 2024
Osteoarthritis, better known as degenerative joint disease, majorly impacts the neck, knees, hips, lower back, and small joints of fingers. The disease progresses gradually, which results in moderate to severe pain in the body parts mentioned above, and low quality of life, especially in the population subject to low physical
Rep Id : TMRGL47571 | Published | Pharmaceutical | February 2024
Cancer is a category of diseases characterized by abnormal cell formation with the potential to afflict or spread to other parts of the body. Carcinomas, sarcomas, lymphomas, and leukemia are all common types of tumors. Sarcomas begin in connective tissues such as muscle or bones.
Rep Id : TMRGL12458 | Published | Pharmaceutical | December 2023
The global prostate cancer therapeutics market outlook appears positive. Substantial progress has been made in prostate cancer androgen receptor targeting in the past 10 years. The best way to apply immunotherapy and radiopharmaceutical-based treatment in the clinic is yet unknown, but both have made strides.
Rep Id : TMRGL6562 | Published | Pharmaceutical | July 2022
Immunotherapy is a cancer treatment that improves the immune system's ability to fight cancer. It is a kind of biological treatment. Biological therapy makes use of compounds derived from biological creatures or lab-created copies of these substances.
Rep Id : TMRGL4312 | Published | Pharmaceutical | June 2022
TMR’s report on the implantable medical devices market in the U.S. studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the implantable medical devices market in
Rep Id : TMRGL326 | Published | Pharmaceutical | April 2022
This report on the global basal cell carcinoma treatment market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary
Rep Id : TMRGL40139 | Published | Pharmaceutical | November 2021
This report studies the current as well as future prospects of the global adult malignant glioma therapeutics market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of malignant glioma therapeutics and new entrants planning to enter the market.
Rep Id : TMRGL13211 | Published | Pharmaceutical | November 2021
Changes in lifestyle and obesity are some of the key risk factors causing breast cancer. The incidence of the disease is more prevalent in women than in men, and is aggravated by the presence of several co-morbidity factors, with no clear causes. According to Breastcancer.org, a non-profit organization working on
Rep Id : TMRGL5678 | Published | Pharmaceutical | November 2021
The prevention of disease through vaccination is one of the most cost-effective and safe ways. Pneumococcus is one of the leading causes of blood infection, pneumonia, sinusitis, meningitis, and otitis media.
Rep Id : TMRGL36536 | Published | Pharmaceutical | December 2017
Chronic Myelogenous Leukemia (CML) takes place when the bone marrow starts making too many white blood cells. This may affect red blood cells, white blood cells, and platelets. The first line treatment for CML in chronic phase is being largely treated with targeted drugs such as tyrosine kinase inhibitors (TKIs)
Rep Id : TMRGL34940 | Published | Pharmaceutical | November 2017
The global rare hematology market is expected to witness a healthy growth attributed to growing prevalence of blood related disorders. Surge in demand to conduct the diagnosis process at the early phase is expected to impact growth of the global rare hematology market significantly.
Rep Id : TMRGL34736 | Published | Pharmaceutical | November 2017
The market for oncology biosimilars has just a few players and hence is consolidated in nature. Big shot players in the market are seen forging carefully-considered collaborations to expand their geographical footprints. A case in point is Dr. Reddy’s Laboratories, which entered into an agreement with TR-Pharm to strengthen its
Rep Id : TMRGL14696 | Published | Pharmaceutical | September 2017
Monoclonal antibodies are a type of biological therapy used in the treatment serious conditions such as cancer, rheumatoid arthritis, Crohn’s diseases, psoriasis, osteoporosis, systemic lupus erythematous, and others. Monoclonal antibody are target specific in action by not affect the other cells of the body thus restores the immune system.
Rep Id : TMRGL18209 | Published | Pharmaceutical | January 2017
This report provides the market analysis for various technologies and applications used for the enrichment and detection of circulating tumor cells (CTCs). The stakeholders of this report include companies and research institutes involved in the production of prognosis kits and research and development activities related to circulating tumor cells technologies
Rep Id : TMRGL2497 | Published | Pharmaceutical | June 2014
Most comprehensive coverage 100+ countries, 2 million+ data points
Personalized pre-sales, on-boarding, and post-sales support
Less assumption, more science - a research methodology perfected through years of rigorous diligence
True to its name, transparency in every minute details from research processes to financials
20% of Fortune 500 are our clients have worked with over 3000 SMEs
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
